These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 5800593

  • 1. Preparation and clinical use of factor IX concentrate PPSB according to Soulier.
    Haanen C, McShine RL, Kunst A.
    Vox Sang; 1969 Apr; 16(4):398-411. PubMed ID: 5800593
    [No Abstract] [Full Text] [Related]

  • 2. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
    Sultan Y, Boyeldieu D, Stieltjes N.
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36 Suppl 1():S59-60. PubMed ID: 8177717
    [Abstract] [Full Text] [Related]

  • 3. Activated prothrombin concentrate for patients with factor VIII inhibitors.
    Kurczynski EM, Penner JA.
    N Engl J Med; 1974 Jul 25; 291(4):164-7. PubMed ID: 4834485
    [No Abstract] [Full Text] [Related]

  • 4. [Longitudinal study of factors X, IX, VIII, V, II and I in the first 6 months of life].
    Duvina PL, Simoni MR, Pezzati M, Poggi G, Rosati C, Trampi F, Duvina G.
    Minerva Pediatr; 1987 May 31; 39(10):421-36. PubMed ID: 3116376
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Preparation of factor IX concentrate with the use of DEAE-cellulose and its therapeutic results].
    Uszyński L, Poszwiński P.
    Acta Haematol Pol; 1971 May 31; 2(2):109-14. PubMed ID: 5170671
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gel filtration properties of factors II, VII, IX, IX a , and X.
    Osterud B, Schiffman S.
    Thromb Diath Haemorrh; 1972 Oct 31; 28(2):317-24. PubMed ID: 4629507
    [No Abstract] [Full Text] [Related]

  • 9. [Determination of blood clotting factor activity in PPSB].
    Tarasova LN, Saltykova ZA.
    Vopr Med Khim; 1974 Oct 31; 20(4):440-2. PubMed ID: 4462299
    [No Abstract] [Full Text] [Related]

  • 10. Congenital hypoprothrombinemia in a Portuguese family.
    Pina-Cabral JM, Justiça B.
    Thromb Diath Haemorrh; 1973 Dec 31; 30(3):451-9. PubMed ID: 4787667
    [No Abstract] [Full Text] [Related]

  • 11. Coagulation in cephalhaematomas.
    Ströder J, Mingers AM.
    Z Kinderheilkd; 1974 Dec 31; 116(4):153-61. PubMed ID: 4825915
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of hemophilia B with a new clotting-factor concentrate.
    Hoag MS, Johnson FF, Robinson JA, Aggeler PM.
    N Engl J Med; 1969 Mar 13; 280(11):581-6. PubMed ID: 5764825
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antihemophilic factor inhibitors. Management with prothrombin complex concentrates.
    Kelly P, Penner JA.
    JAMA; 1976 Nov 01; 236(18):2061-4. PubMed ID: 989788
    [Abstract] [Full Text] [Related]

  • 18. Clotting mechanisms in patients with hypertriglyceridemia during therapy with anabolic or progestational drugs.
    Glueck HI, Glueck CJ.
    Thromb Diath Haemorrh; 1973 May 10; 29(2):499-509. PubMed ID: 4762263
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Prevention of severe haemophilia B with a factor IX concentrate (author's transl)].
    Ludwig E, Lechner K.
    Dtsch Med Wochenschr; 1974 Jun 21; 99(25):1355-61. PubMed ID: 4836072
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.